Does ABATACEPT Cause Squamous cell carcinoma? 86 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Squamous cell carcinoma have been filed in association with ABATACEPT (ORENCIA). This represents 0.1% of all adverse event reports for ABATACEPT.
86
Reports of Squamous cell carcinoma with ABATACEPT
0.1%
of all ABATACEPT reports
3
Deaths
15
Hospitalizations
How Dangerous Is Squamous cell carcinoma From ABATACEPT?
Of the 86 reports, 3 (3.5%) resulted in death, 15 (17.4%) required hospitalization, and 2 (2.3%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
Yes, Squamous cell carcinoma is listed as a known adverse reaction in the official FDA drug label for ABATACEPT.
What Other Side Effects Does ABATACEPT Cause?
Drug ineffective (35,212)
Rheumatoid arthritis (21,898)
Pain (19,783)
Arthralgia (18,536)
Joint swelling (18,453)
Contraindicated product administered (13,559)
Fatigue (13,087)
Drug intolerance (12,451)
Rash (12,168)
Arthropathy (11,099)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which ABATACEPT Alternatives Have Lower Squamous cell carcinoma Risk?
ABATACEPT vs ABATACEPT SUBQ /ML
ABATACEPT vs ABCIXIMAB
ABATACEPT vs ABEMACICLIB
ABATACEPT vs ABILIFY
ABATACEPT vs ABIRATERONE